CV Sciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Acquisitions (Tables)

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2024

Summary Of Total Consideration Transferred Of Acquisition Date

The following table outlines the total consideration transferred as of the acquisition date (in thousands):


Cash	$	192
Common shares		250
Earn-out		88
Total consideration transferred	$	530

Summary Of Assets Acquired And Liabilities Assumed Of Acquisition Date

The following table summarizes the assets acquired and liabilities assumed as of the acquisition date (in thousands):


Cash	$	18
Accounts receivable and other receivables		11
Inventories		133
Intangible assets		78
Other current assets		17
Fixed assets		38
Goodwill		334
Total assets		629

Accounts payable and accrued liabilities		27
Current note payable		50
Deferred tax liabilities		22
Total liabilities		99
Net assets acquired	$	530

Elevated Softgels

Business Acquisition [Line Items]

Summary Of Total Consideration Transferred Of Acquisition Date

The following table outlines the total consideration transferred as of the acquisition date (in thousands):


Cash	$	41
Common shares		871
Earn-out		100
Total consideration transferred	$	1,012

Summary Of Assets Acquired And Liabilities Assumed Of Acquisition Date

The following table summarizes the assets and liabilities assumed as of the acquisition date, updated for certain measurement adjustments (in thousands):


Cash	$	31
Inventories		49
Intangible assets		38
Other non-current assets		11
Fixed assets		316
Goodwill		640
Total assets		1,085

Accounts payable and accrued liabilities		73
Total liabilities		73
Net assets acquired	$	1,012